Merck’s drug for bacterial infection leads to fatal diarrhea
merck
December, 24 2024
(Web Desk) Merck will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug Administration's website showed on Monday.
The antibody drug, Zinplava, was first approved by the regulator in 2016 to prevent the recurrence of Clostridioides difficile infections (CDI).
CDI is generally caused by prolonged use of antibiotics, and can lead to potentially fatal diarrhea and inflammation of the colon.
The drugmaker did not immediately comment on the matter.
Zinplava will be discontinued on Jan. 31, the regulator s website showed, but no reason was cited for the decision.
سحر و افطار اوقات
09 March 2026, 19th Ramadan
Must Read
Germany opens fully funded Einstein Fellowship for Pakistani researchers
March, 8 2026
LPG prices soar in Pakistan amid Middle East tensions
March, 8 2026
Airlines brace for fare hikes after jet fuel price jump in Pakistan
March, 8 2026
British Council announces fully funded women in STEM scholarships in UK
March, 7 2026